Kissei consults Japan regulators after EU panel recommends revoking Tavneos
The CHMP said Tavneos’ benefits had not been shown to outweigh its risks after a review linked to phase III data-integrity concerns, leaving Kissei to assess Japan’s response and any earnings effect.